Cathie Wood, of ARK Genomic Revolution ETF(NYSE: ARKG) explains the multi-trillion dollar opportunity in the Genomics Revolution: CAR-T, CRISPR, and DNA Sequencing
Cathie Wood, of ARK Genomic Revolution ETF(NYSE: ARKG) explains the multi-trillion dollar opportunity in the Genomics Revolution: CAR-T, CRISPR, and DNA Sequencing
Interview with Thomas Grimes, Reaves Asset Management Friendly regulatory environment positions utilities for growth. Discover Tomorrow’s Winning Stocks! Thank you for subscribing. Something went wrong. Get our latest stock reports before everyone else! Actionable news, […]
VANCOUVER, Washington, Feb 01, 2019 — Successful interim results in the 700 mg monotherapy arm prompted the FDA to allow CytoDyn to switch all remaining combination therapy patients from CD02-Extension study from 350 mg to […]
Investing Legend, Ron Baron, explains why he believes Tesla is headed much higher. Ron Baron originally owned TSLA around $3, sold around $30 for 10X gain in a few years. Then he “realized his mistake” […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
